
Following this week's Science of Skin media roundtable hosted by AbbVie, panelist and dual-board certified dermatologist and psychiatrist Evan Rieder, MD, discusses the relationship between chronic skin conditions and mental health.

Following this week's Science of Skin media roundtable hosted by AbbVie, panelist and dual-board certified dermatologist and psychiatrist Evan Rieder, MD, discusses the relationship between chronic skin conditions and mental health.

Researchers found that STAT3 could be activated, and inhibition could be achieved in patients with hypertrophic scarring.

While the linkage between squamous cell cancers and genital lichen sclerosus has been well-established, fewer studies have examined the associations between penile melanomas in males.

The study is the first large study to assess skin cancer screening efforts aimed at volunteer firefighters in the US.

Piction Health Dermatology seeks to break down barriers in dermatologic care access.

This Hair Loss Awareness Month, test your knowledge of hair loss conditions. Click here to answer this week's poll.

Keep up with the latest headlines in dermatology from the past week, including a newly-developed electronic skin, the first ever use of CRISPR technology to explore the genetics of human melanin production, and more.

The Soligenix study is supported by a US Food and Drug Administration Orphan Products Development grant award.

The highly selective oral BTK inhibitor is emerging in the treatment landscape as a potential therapeutic option for urticaria uncontrolled by H1-antihistamines.

The treatments also led to a decrease in the density of immunohistochemistry of sweat glands.

Dermatology Times is counting down to the annual fall SDPA conference in Nashville, Tennessee, with our top 10 headlines and highlights from this year's summer conference.

Researchers conducted systematic mapping of relevant DHI literature to determine the impact of these interventions on dermatologic care outcomes.

The guidance draft, once finalized, will enable the US FDA to have more oversight in the realm of cosmetic safety.

During the 25th World Congress of Dermatology, 40 rising stars and personalities were spotlighted for their contributions to the field.

This Psoriasis Awareness Month, test your knowledge of the condition. Click here to answer this week's poll.

Keep up with the latest headlines in dermatology from the past week, including cercarial dermatitis cases popping up across beaches in Connecticut, reports of Florida dermatologists encountering patients with leprosy, and more.

ICYMI, this week we had stories about laser treatments for port wine stain birthmarks, Abeona's briefing package filing for the BLA for its anticipated epidermolysis bullosa drug, using digital apps to detect skin cancers, and more.

The most common comorbidities identified included anxiety, dermatitis, hyperthyroidism, hyperlipidemia, and vitamin D deficiency.

While both cryotherapy and plasma exeresis are effective in clearing seborrheic keratosis lesions, researchers observed more statistically significant clearance in patients treated with plasma exeresis.

Researchers found that use of personal protective equipment could be associated with skin problems; however, protective applications reduced these skin-related problems.

Supplements were based on amino acids and hydrolyzed collagen and were tested in patients with androgenic alopecia and chronic telogen effluvium.

The multi-million-dollar study will identify signatures of at-risk patients that may predispose them to developing vitiligo.

A pediatric patient with treatment-resistant vitiligo experienced improvements in depigmentation in as few as 9 treatments.

A systematic review found that combination therapy proved more efficacious in treating patients with vitiligo as opposed to the excimer laser alone.

Peter Lio, MD, discusses pearls and takeaways from the atopic dermatitis panel he participated in at the 2023 Society of Pediatric Dermatology meeting.

Platinum Dermatology Partners and West Dermatology merged in June 2022 and now have completed a post-integration rebranding.

The company is set to meet with the FDA in August to discuss the epidermolysis bullosa drug’s anticipated BLA.

Shari Lipner, MD, PhD, FAAD, shared advice for providers and patients in the event of nail injuries.

Keep up with the latest headlines in dermatology from the past week, including rising incidences of skin cancer, dermatologists' responses to viral social media skin care tips, and more.

This increased risk was particularly heightened among pediatric patients who fell under an anxious pre-occupied subcategory.